Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Toronto

$33,000.00

Regulation of Low-Affinity Folate Transporters in the Brain

EF 2017-18

Résumé
Folates are water soluble vitamins that play a critical role in tissue development, function and repair. Humans must obtain folate from their diet since they cannot synthesize it from other nutrients. Folate deficiency is one of the major dietary health problems worldwide and is associated with significant disturbances that affect tissues such as bone marrow, intestine and developing brain. Folates being negatively charged water soluble molecules at physiological pH cross biological membranes very poorly by diffusion and thus need specific membrane carriers (transporters) for intestinal uptake and to gain access to vital organs such as the brain. A number of folate transporters have been identified in several tissues including the intestine, kidney and brain. In particular, the folate receptors alpha (FRa) constitutes a major transport pathway in the brain. Folate transport is critical for the maintenance of normal brain function. FRa mutations and/or presence of antibodies against this receptor can cause severe folate deficiency and result in childhood neurodegeneration. To date, folate transport in the brain has been largely investigated through the FRa; however, little is known on the properties of other folate transporters in the brain. Apart from the FRa, there are at least two other transport systems for folates, which have lower affinity for folates compared to FRa, i.e. require higher folate concentrations. In the intestine, folate transport is mediated by the proton-coupled folate transporter (PCFT) which functions optimally at acidic pH. The reduced folate carrier (RFC) is another low affinity folate transporter which exchanges folate with other inorganic or organic anions. At present, the contribution of these transporters to the overall brain folate uptake remains unclear. Recent studies report that PCFT and RFC can be regulated by nuclear receptors, in particular, the vitamin D receptor (VDR). We propose that in the context of FRa mutations and/or presence of FRa antibodies which render this mechanism of folate transport ineffective, the low affinity folate transporters could play a significant role in brain folate uptake. Furthermore, the induction of the same transporters may provide alternative routes for effective folate penetration into the brain. The objectives of this proposal are to investigate the contribution of the low affinity folate transporters, PCTF and RFC, in folate uptake by several brain cellular models and to examine the role of nuclear receptors i.e., VDR, in folate transporter regulation using animal mouse models lacking FRa. It is anticipated that an induction of the folate transporters i.e., PCFT, through administration of specific VDR ligands will result in an enhanced brain uptake of folate derivatives. This work could uncover novel strategies for the treatment of brain disorders caused by folic acid deficiency.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2015-04459
Name nom
Bendayan, Reina
Department département
Pharmaceutical Sciences - Pharmaceutical Sciences
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2015
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5303
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene regulation
Research subject fr
Régulation des gènes
Partie
3
Nb partie
5
Application title
Regulation of Low-Affinity Folate Transporters in the Brain
Keyword
NSERC
Application summary
Folates are water soluble vitamins that play a critical role in tissue development, function and repair. Humans must obtain folate from their diet since they cannot synthesize it from other nutrients. Folate deficiency is one of the major dietary health problems worldwide and is associated with significant disturbances that affect tissues such as bone marrow, intestine and developing brain. Folates being negatively charged water soluble molecules at physiological pH cross biological membranes very poorly by diffusion and thus need specific membrane carriers (transporters) for intestinal uptake and to gain access to vital organs such as the brain. A number of folate transporters have been identified in several tissues including the intestine, kidney and brain. In particular, the folate receptors alpha (FRa) constitutes a major transport pathway in the brain. Folate transport is critical for the maintenance of normal brain function. FRa mutations and/or presence of antibodies against this receptor can cause severe folate deficiency and result in childhood neurodegeneration. To date, folate transport in the brain has been largely investigated through the FRa; however, little is known on the properties of other folate transporters in the brain. Apart from the FRa, there are at least two other transport systems for folates, which have lower affinity for folates compared to FRa, i.e. require higher folate concentrations. In the intestine, folate transport is mediated by the proton-coupled folate transporter (PCFT) which functions optimally at acidic pH. The reduced folate carrier (RFC) is another low affinity folate transporter which exchanges folate with other inorganic or organic anions. At present, the contribution of these transporters to the overall brain folate uptake remains unclear. Recent studies report that PCFT and RFC can be regulated by nuclear receptors, in particular, the vitamin D receptor (VDR). We propose that in the context of FRa mutations and/or presence of FRa antibodies which render this mechanism of folate transport ineffective, the low affinity folate transporters could play a significant role in brain folate uptake. Furthermore, the induction of the same transporters may provide alternative routes for effective folate penetration into the brain. The objectives of this proposal are to investigate the contribution of the low affinity folate transporters, PCTF and RFC, in folate uptake by several brain cellular models and to examine the role of nuclear receptors i.e., VDR, in folate transporter regulation using animal mouse models lacking FRa. It is anticipated that an induction of the folate transporters i.e., PCFT, through administration of specific VDR ligands will result in an enhanced brain uptake of folate derivatives. This work could uncover novel strategies for the treatment of brain disorders caused by folic acid deficiency.